Print page

Engaging in partnerships to combat vector-borne diseases is a key aspect of our 360° Vector Control approach. These can extend from multi-stakeholder initiatives with governments and NGOs to collaborative research projects with universities and business initiatives. We find that sharing knowledge and know-how gives us inspiration and provides us with an opportunity to share new ideas on prevention and control across geographically relevant areas. 

Bayer is involved in various partnerships with other organisations such as the London School of Hygiene and Tropical Medicine, the Innovative Vector Control Consortium (IVCC), GBCHealth*, AMP* and is a member of the private sector delegation for Roll Back Malaria Partnership.